Poster: HL-089 Outcomes in Patients With New Diagnose of Hodgkin Disease: Real-World Data in Public Health Institution in Mexico Without Access to Anti-CD30 and PD-1 Checkpoint Inhibitors in First-Line Therapy

Autor: Duque, Guillermo Sotomayor, Cerda, Yarezi Brislett Garcia, Villarreal, Jose Alfredo Carrizales, Arellano, Severiano Baltazar, de la Cerda, José Luis Cedillo, Leal, Martha Lilia Guajardo, Contreras, Diego Gustavo Cruz, Dávila, Helga Patricia Sorkee, Luevano, Myrna Patricia Pequeño, Gutierrez, Dora Carolina Aldama, Escobar, Juan Daniel Garza, Bugarin, Victor Valerio, Adame, Karen Michelle Machuca, Cobos, Luis Omar Gudiño, Martinez, Dania Getsemani Contreras, Gonzalez, Raul Sergio Campillo, Nevárez, Tania Beltran, Vazquez, Roxana Saldaña, Cantu, Rosa Elva De León, Valdes, Roberto Hernandez
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S161-S161
Databáze: ScienceDirect
Externí odkaz: